The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

This study examines how genetic testing for drug responses (called pharmacogenomics) can be implemented into routine outpatient care, to help doctors choose the right medications and doses based on each patient's unique genetic makeup. **You may be eligible if...** - You are 18 years or older and receiving ongoing outpatient care at the University of Chicago Medical Center - You are currently taking 1-6 prescription medications, OR you are 65 or older, OR you are expected to need a prescription drug within the next 5 years - You have a life expectancy of at least 3 years **You may NOT be eligible if...** - You have a serious illness expected to cause death within 3 years - You have undergone or are being considered for a liver or kidney transplant - You are unable to understand and give informed consent Talk to your doctor to see if this trial is right for you.